 use esmolol unstabl angina pectori european esmolol studi group esmolol new cardioselect beta blocker uniqu pharmacokinet properti half-lif minut present multicent placebo-control studi hemodynam antiischem effect compound adjunct convent medic therapi patient unstabl angina fifty-nin patient esmolol match placebo infus esmolol step-wis manner dosag mg/min reduct doubl product esmolol hour esmolol signific persist declin heart rate blood pressur entir studi period clinic event develop acut myocardi infarct need urgent revascular esmolol placebo patient trend reduct silent ischemia holter monitor mean standard deviat hour minut esmolol minut placebo group esmolol-rel advers effect cardiovascular origin downward dose titrat cessat drug infus esmolol safe effect drug patient unstabl angina larg degre flexibl desir level beta blockad patient clinic present